88 related articles for article (PubMed ID: 9568047)
1. Expression of the kidney-associated differentiation glycoprotein gp160 and resistance to the antitumor effects of interferon alpha in renal cell carcinomas.
Geng Y; Biffi A; Engelstein D; Ronch E; Faustini M; Lai HK; Albino AP; Di Fronzo G; Nanus DM
Anticancer Res; 1998; 18(1A):1-7. PubMed ID: 9568047
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative and antitumor effects of alpha-interferon in renal cell carcinomas: correlation with the expression of a kidney-associated differentiation glycoprotein.
Nanus DM; Pfeffer LM; Bander NH; Bahri S; Albino AP
Cancer Res; 1990 Jul; 50(14):4190-4. PubMed ID: 2364374
[TBL] [Abstract][Full Text] [Related]
3. [Expression of GP160 mRNA in renal cell carcinoma: an attempt to predict the sensitivity of IFN-alpha therapy].
Kimura F; Shimizu S; Tsuji A; Nakajima F; Hayakawa M; Nakamura H
Nihon Hinyokika Gakkai Zasshi; 1995 Sep; 86(9):1424-8. PubMed ID: 7474630
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning of the human kidney differentiation antigen gp160: human aminopeptidase A.
Nanus DM; Engelstein D; Gastl GA; Gluck L; Vidal MJ; Morrison M; Finstad CL; Bander NH; Albino AP
Proc Natl Acad Sci U S A; 1993 Aug; 90(15):7069-73. PubMed ID: 8346219
[TBL] [Abstract][Full Text] [Related]
5. Aminopeptidase A expression and enzymatic activity in primary human renal cancers.
Nanus DM; Bogenrieder T; Papandreou CN; Finstad CL; Lee A; Vlamis V; Motzer RJ; Bander NH; Albino AP; Reuter VE
Int J Oncol; 1998 Aug; 13(2):261-7. PubMed ID: 9664120
[TBL] [Abstract][Full Text] [Related]
6. Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro.
Motzer RJ; Schwartz L; Law TM; Murphy BA; Hoffman AD; Albino AP; Vlamis V; Nanus DM
J Clin Oncol; 1995 Aug; 13(8):1950-7. PubMed ID: 7636535
[TBL] [Abstract][Full Text] [Related]
7. [Expression of major histocompatibility complex antigens and adhesion molecules on renal cell carcinoma cells, and effect of interferon-alpha and/or cimetidine on the expression].
Wu XX; Mizutani Y; Kakehi Y; Nakamura E; Mitsumori K; Takahashi T; Terachi T; Okada Y; Yoshida O
Hinyokika Kiyo; 1998 Sep; 44(9):621-6. PubMed ID: 9805665
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the antitumor activities of IFN-alpha8 on renal cell carcinoma cells in vitro.
Yanai Y; Horie S; Yamamoto K; Yamauchi H; Ikegami H; Kurimoto M; Kitamura T
J Interferon Cytokine Res; 2001 Dec; 21(12):1129-36. PubMed ID: 11798471
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the expression of aminopeptidase A, aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 in renal carcinoma cells and renal tubular epithelial cells by cytokines and cAMP-increasing mediators.
Kehlen A; Göhring B; Langner J; Riemann D
Clin Exp Immunol; 1998 Feb; 111(2):435-41. PubMed ID: 9486416
[TBL] [Abstract][Full Text] [Related]
10. Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon gamma.
Gastl G; Ebert T; Finstad CL; Sheinfeld J; Gomahr A; Aulitzky W; Bander NH
J Urol; 1996 Jan; 155(1):361-7. PubMed ID: 7490887
[TBL] [Abstract][Full Text] [Related]
11. Differential profiling analysis of proteins involved in anti-proliferative effect of interferon-alpha on renal cell carcinoma cell lines by protein biochip technology.
Nakamura K; Yoshikawa K; Yamada Y; Saga S; Aoki S; Taki T; Tobiume M; Shimazui T; Akaza H; Honda N
Int J Oncol; 2006 Apr; 28(4):965-70. PubMed ID: 16525647
[TBL] [Abstract][Full Text] [Related]
12. [Antiproliferative effect of interferon-alpha on human renal cell carcinoma in clonogenic assay--single and combination effect with cancer chemotherapeutic agent].
Ohmura K; Tsukamoto T
Hinyokika Kiyo; 1989 May; 35(5):737-47. PubMed ID: 2801371
[TBL] [Abstract][Full Text] [Related]
13. Determination of in vitro drug sensitivity to a panel of cystostatic drugs and interferon alpha-2b in patients with renal cell carcinoma.
Küpeli S; Beksac M; Küpeli B; Baltaci S; Süzer O
Int Urol Nephrol; 1997; 29(4):421-6. PubMed ID: 9405998
[TBL] [Abstract][Full Text] [Related]
14. Interferon-α induces G1 cell-cycle arrest in renal cell carcinoma cells via activation of Jak-Stat signaling.
Shang D; Yang P; Liu Y; Song J; Zhang F; Tian Y
Cancer Invest; 2011 Jun; 29(5):347-52. PubMed ID: 21599510
[TBL] [Abstract][Full Text] [Related]
15. Interferon-alpha (IFN-alpha)-conditioned DC preferentially stimulate type-1 and limit Treg-type in vitro T-cell responses from RCC patients.
Gigante M; Mandic M; Wesa AK; Cavalcanti E; Dambrosio M; Mancini V; Battaglia M; Gesualdo L; Storkus WJ; Ranieri E
J Immunother; 2008 Apr; 31(3):254-62. PubMed ID: 18317362
[TBL] [Abstract][Full Text] [Related]
16. Biologic and binding activities of IFN-alpha subtypes in ACHN human renal cell carcinoma cells and Daudi Burkitt's lymphoma cells.
Yamaoka T; Kojima S; Ichi S; Kashiwazaki Y; Koide T; Sokawa Y
J Interferon Cytokine Res; 1999 Dec; 19(12):1343-9. PubMed ID: 10638703
[TBL] [Abstract][Full Text] [Related]
17. Treatment with tumor necrosis factor alpha and interferon alpha of a human kidney cancer xenograft in nude mice: evidence for an anticachectic effect of interferon alpha.
Bassukas ID; Hofmockel G; Maurer-Schultze B
Anticancer Res; 1994; 14(1A):237-45. PubMed ID: 8166454
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of the enzyme that esterifies retinol, lecithin:retinol acyltransferase, in subtypes of human renal cancer and normal kidney.
Zhan HC; Gudas LJ; Bok D; Rando R; Nanus DM; Tickoo SK
Clin Cancer Res; 2003 Oct; 9(13):4897-905. PubMed ID: 14581364
[TBL] [Abstract][Full Text] [Related]
19. Comparative expression profiling for human endoplasmic reticulum-resident aminopeptidases 1 and 2 in normal kidney versus distinct renal cell carcinoma subtypes.
Stoehr CG; Buettner-Herold M; Kamphausen E; Bertz S; Hartmann A; Seliger B
Int J Clin Exp Pathol; 2013; 6(6):998-1008. PubMed ID: 23696916
[TBL] [Abstract][Full Text] [Related]
20. Maximal COX-2 immunostaining and clinical response to celecoxib and interferon alpha therapy in metastatic renal cell carcinoma.
Rini BI; Weinberg V; Dunlap S; Elchinoff A; Yu N; Bok R; Simko J; Small EJ
Cancer; 2006 Feb; 106(3):566-75. PubMed ID: 16369983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
